Logo image of ALBFR.PA

SIDETRADE (ALBFR.PA) Stock Fundamental Analysis

Europe - EPA:ALBFR - FR0010202606 - Common Stock

252 EUR
0 (0%)
Last: 10/21/2025, 7:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ALBFR. ALBFR was compared to 110 industry peers in the Software industry. ALBFR scores excellent on profitability, but there are some minor concerns on its financial health. ALBFR is valued quite expensive, but it does show an excellent growth. This makes ALBFR very considerable for growth investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ALBFR had positive earnings in the past year.
In the past year ALBFR had a positive cash flow from operations.
In the past 5 years ALBFR has always been profitable.
In the past 5 years ALBFR always reported a positive cash flow from operatings.
ALBFR.PA Yearly Net Income VS EBIT VS OCF VS FCFALBFR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

With a decent Return On Assets value of 9.46%, ALBFR is doing good in the industry, outperforming 79.09% of the companies in the same industry.
ALBFR has a Return On Equity of 19.66%. This is amongst the best in the industry. ALBFR outperforms 80.91% of its industry peers.
ALBFR has a Return On Invested Capital of 9.28%. This is in the better half of the industry: ALBFR outperforms 70.00% of its industry peers.
ALBFR had an Average Return On Invested Capital over the past 3 years of 8.57%. This is below the industry average of 12.42%.
The last Return On Invested Capital (9.28%) for ALBFR is above the 3 year average (8.57%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.46%
ROE 19.66%
ROIC 9.28%
ROA(3y)8.09%
ROA(5y)8.31%
ROE(3y)16.87%
ROE(5y)17.25%
ROIC(3y)8.57%
ROIC(5y)9.37%
ALBFR.PA Yearly ROA, ROE, ROICALBFR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

ALBFR has a Profit Margin of 14.17%. This is in the better half of the industry: ALBFR outperforms 67.27% of its industry peers.
ALBFR's Profit Margin has improved in the last couple of years.
ALBFR has a Operating Margin of 10.85%. This is in the better half of the industry: ALBFR outperforms 63.64% of its industry peers.
ALBFR's Operating Margin has improved in the last couple of years.
ALBFR has a Gross Margin (75.88%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ALBFR has grown nicely.
Industry RankSector Rank
OM 10.85%
PM (TTM) 14.17%
GM 75.88%
OM growth 3Y-11.7%
OM growth 5Y3.49%
PM growth 3Y-0.3%
PM growth 5Y10.94%
GM growth 3Y2.02%
GM growth 5Y2.88%
ALBFR.PA Yearly Profit, Operating, Gross MarginsALBFR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALBFR is still creating some value.
ALBFR has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ALBFR has been increased compared to 5 years ago.
The debt/assets ratio for ALBFR has been reduced compared to a year ago.
ALBFR.PA Yearly Shares OutstandingALBFR.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
ALBFR.PA Yearly Total Debt VS Total AssetsALBFR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 6.73 indicates that ALBFR is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 6.73, ALBFR is doing good in the industry, outperforming 73.64% of the companies in the same industry.
The Debt to FCF ratio of ALBFR is 1.10, which is an excellent value as it means it would take ALBFR, only 1.10 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ALBFR (1.10) is better than 76.36% of its industry peers.
A Debt/Equity ratio of 0.16 indicates that ALBFR is not too dependend on debt financing.
ALBFR has a better Debt to Equity ratio (0.16) than 64.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.1
Altman-Z 6.73
ROIC/WACC1.06
WACC8.77%
ALBFR.PA Yearly LT Debt VS Equity VS FCFALBFR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

ALBFR has a Current Ratio of 1.47. This is a normal value and indicates that ALBFR is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.47, ALBFR perfoms like the industry average, outperforming 57.27% of the companies in the same industry.
A Quick Ratio of 1.47 indicates that ALBFR should not have too much problems paying its short term obligations.
The Quick ratio of ALBFR (1.47) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.47
ALBFR.PA Yearly Current Assets VS Current LiabilitesALBFR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.87% over the past year.
The Earnings Per Share has been growing by 27.85% on average over the past years. This is a very strong growth
The Revenue has grown by 24.74% in the past year. This is a very strong growth!
The Revenue has been growing by 16.43% on average over the past years. This is quite good.
EPS 1Y (TTM)17.87%
EPS 3Y16.56%
EPS 5Y27.85%
EPS Q2Q%13.63%
Revenue 1Y (TTM)24.74%
Revenue growth 3Y19.06%
Revenue growth 5Y16.43%
Sales Q2Q%18.08%

3.2 Future

ALBFR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.26% yearly.
Based on estimates for the next years, ALBFR will show a quite strong growth in Revenue. The Revenue will grow by 11.57% on average per year.
EPS Next Y12.48%
EPS Next 2Y11.31%
EPS Next 3Y11.26%
EPS Next 5YN/A
Revenue Next Year10.68%
Revenue Next 2Y11.19%
Revenue Next 3Y11.57%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALBFR.PA Yearly Revenue VS EstimatesALBFR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ALBFR.PA Yearly EPS VS EstimatesALBFR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 45.41, which means the current valuation is very expensive for ALBFR.
The rest of the industry has a similar Price/Earnings ratio as ALBFR.
The average S&P500 Price/Earnings ratio is at 27.77. ALBFR is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 37.90, the valuation of ALBFR can be described as expensive.
ALBFR's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 23.23. ALBFR is valued rather expensively when compared to this.
Industry RankSector Rank
PE 45.41
Fwd PE 37.9
ALBFR.PA Price Earnings VS Forward Price EarningsALBFR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ALBFR.
The rest of the industry has a similar Price/Free Cash Flow ratio as ALBFR.
Industry RankSector Rank
P/FCF 61.41
EV/EBITDA 46.49
ALBFR.PA Per share dataALBFR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALBFR does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of ALBFR may justify a higher PE ratio.
PEG (NY)3.64
PEG (5Y)1.63
EPS Next 2Y11.31%
EPS Next 3Y11.26%

0

5. Dividend

5.1 Amount

ALBFR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SIDETRADE

EPA:ALBFR (10/21/2025, 7:00:00 PM)

252

0 (0%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-14 2025-10-14
Earnings (Next)01-20 2026-01-20
Inst Owners18.4%
Inst Owner ChangeN/A
Ins Owners35.29%
Ins Owner ChangeN/A
Market Cap378.00M
Revenue(TTM)59.46M
Net Income(TTM)8.43M
Analysts84
Price Target285.6 (13.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.75%
PT rev (3m)-1.75%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.18%
EPS NY rev (3m)1.74%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.79%
Valuation
Industry RankSector Rank
PE 45.41
Fwd PE 37.9
P/S 6.36
P/FCF 61.41
P/OCF 53.42
P/B 8.82
P/tB 31.67
EV/EBITDA 46.49
EPS(TTM)5.55
EY2.2%
EPS(NY)6.65
Fwd EY2.64%
FCF(TTM)4.1
FCFY1.63%
OCF(TTM)4.72
OCFY1.87%
SpS39.64
BVpS28.58
TBVpS7.96
PEG (NY)3.64
PEG (5Y)1.63
Graham Number59.74
Profitability
Industry RankSector Rank
ROA 9.46%
ROE 19.66%
ROCE 12.63%
ROIC 9.28%
ROICexc 19.81%
ROICexgc N/A
OM 10.85%
PM (TTM) 14.17%
GM 75.88%
FCFM 10.35%
ROA(3y)8.09%
ROA(5y)8.31%
ROE(3y)16.87%
ROE(5y)17.25%
ROIC(3y)8.57%
ROIC(5y)9.37%
ROICexc(3y)18.44%
ROICexc(5y)20.75%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.66%
ROCE(5y)12.74%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-1.75%
ROICexc growth 5Y5.4%
OM growth 3Y-11.7%
OM growth 5Y3.49%
PM growth 3Y-0.3%
PM growth 5Y10.94%
GM growth 3Y2.02%
GM growth 5Y2.88%
F-Score6
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.1
Debt/EBITDA 0.88
Cap/Depr 74.39%
Cap/Sales 1.55%
Interest Coverage 250
Cash Conversion 91.99%
Profit Quality 73.03%
Current Ratio 1.47
Quick Ratio 1.47
Altman-Z 6.73
F-Score6
WACC8.77%
ROIC/WACC1.06
Cap/Depr(3y)191.5%
Cap/Depr(5y)202.1%
Cap/Sales(3y)4.08%
Cap/Sales(5y)4.13%
Profit Quality(3y)97.77%
Profit Quality(5y)121.95%
High Growth Momentum
Growth
EPS 1Y (TTM)17.87%
EPS 3Y16.56%
EPS 5Y27.85%
EPS Q2Q%13.63%
EPS Next Y12.48%
EPS Next 2Y11.31%
EPS Next 3Y11.26%
EPS Next 5YN/A
Revenue 1Y (TTM)24.74%
Revenue growth 3Y19.06%
Revenue growth 5Y16.43%
Sales Q2Q%18.08%
Revenue Next Year10.68%
Revenue Next 2Y11.19%
Revenue Next 3Y11.57%
Revenue Next 5YN/A
EBIT growth 1Y16.13%
EBIT growth 3Y5.13%
EBIT growth 5Y20.49%
EBIT Next Year10%
EBIT Next 3Y10.69%
EBIT Next 5YN/A
FCF growth 1Y158.83%
FCF growth 3Y12.94%
FCF growth 5Y37.14%
OCF growth 1Y99.89%
OCF growth 3Y9.02%
OCF growth 5Y29.8%